Sponsors: ACIRAH, Beyond Clinical Walls, Black Women’s Health Imperative, Fibroid Foundation, G2G Consulting, Goodwin Health, Klover Communication, UIC College of Medicine, Walgreens, Women’s Digital Health Network, Women’s Health PAC, and Women in Medicine
*In-person event in Chicago (location shared upon registration confirmation)
Join this special Women’s Health Forum to learn about how women’s health is transforming and what you can do to be a part of this effort. With many national leaders in business, nonprofits and healthcare policy coming to Chicago for the week of the convention, we have the opportunity to convene, collaborate and drive transformational change in women’s health. Join Members of Congress and national leaders for this special event.
SPEAKERS:
- Linda Goler Blount, MPH – CEO, Black Women’s Health Imperative
- Bayo Curry-Winchell, MD — Founder, Beyond Clinical Walls and Urgent Care Medical Director, St. Mary’s Health Network
- Shikha Jain, MD – President & CEO Founder, Women in Medicine® and Associate Professor of Medicine for the Division of Hematology and Oncology and Associate Director of Oncology Communication & Digital Innovation, University of Illinois Cancer Center
- Bridgette Rene McCullough, PhD, Esq. – Founder and CEO, ACIRAH Health, Founding/Executive Committee member of ENRICH-CT, FasterCures Milken Institute and Senior Researcher, Northwestern University Feinberg School of Medicine in Chicago, IRB Certified, Northwestern Pritizker School of Law
- Dana Sun, MBA – Principal, Laerdal Million Lives Fund
- Ramita Tandon, MPH – Chief Clinical Trials Officer, Walgreens
- Crystal Pirtle Tyler, PhD, MPH — CEO, Illinois Public Health Institute
- Kendal Whitlock, MPH – Head of Digital Optimization, RWE Clinical Trials, Walgreens
- Nicole Woitowich, PhD – Executive Director, Northwestern University Clinical and Translational Sciences Institute and a Research Assistant Professor of medical social sciences at Northwestern University Feinberg School of Medicine in Chicago
Registration does not guarantee attendance — first come first served!
The location of the event will be shared only upon confirmation of your attendance.
BACKGROUND:
Women’s health has garnered significant attention over the past year due to founders, investors, researchers, clinicians, patients and advocates all working to contribute to and amplify the opportunities and challenges in this space. With the first-ever White House Initiative on Women’s Health Research kickstarting conversations, collaborations and change followed by the first-ever $100 million investment in women’s health innovation by ARPA-H and the over 20 directives resulting from President Biden’s Executive Order, government has made women’s health a priority.
The time for change has never been clearer with many persistent gaps spanning from maternal health where Black women are 3X more likely to die from a pregnancy-related cause than White women and the U.S. ranks among the worst internationally with growing OB-GYN deserts across the country to autoimmune conditions where women make up 80% of patients and Alzheimer’s where women are 66% of patients yet little is known as to why these sex differences exist. Among cancers, 50% of those diagnosed with ovarian cancer die yet no early diagnostic tool or effective treatment is available. Non-smoking related lung cancers have risen 84% in women while dropping 36% among men over the past 42 years, yet no data exists to explain why. Menopause impacts 100% of women reaching those mid-life years yet stigma and lack of research funding have forced most women to suffer with painful symptoms in silence. Menopause triggers sudden increased prevalence of many conditions (from heart disease to cardiometabolic syndrome to autoimmune conditions) that impact the affected woman’s work, family, and community.
Women live five years longer than men on average but often do not thrive throughout their lives. This can change by prioritizing the health of women in research funding, investment strategies, clinical trial design, how care is provided with meaningful access, FDA approval and CMS reimbursement policies, and much more.
Join this special Women’s Health Forum to learn about the changing landscape in women’s health, investment in research and innovation, clinical trial design and recruitment to ensure participation that is representative of disease impact in the broader population, and patient-centric care models that are shifting the paradigm in how we treat women.
|
|
